Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Clinical trials indicate that percent fat mass drops from a baseline of 4.9% at the lowest dosage of 0.5 mg to as much as 26.1% with 8 mg and 23.2% with 12 mg
Facial changes and reduced bloating are typically the first visible signs
This compounded formulation is not those products and is not interchangeable with them
Its not recommended for anyone who is pregnant, breastfeeding, or has a personal/family history of medullary thyroid carcinoma (MTC) or MEN2
Retatrutide, often shortened to reta, is a peptide that researchers are still testing in clinical trials
The competition was toughthere are a lot of companies out there offering weight loss medications
US$ 20.63
US$ 29.56
US$ 28.49
